Business

Latest News

Vials and Syringe on White Table with Background Windows Stock Photo | © iStockPhoto.com
Secukinumab Found Cost-Effective for Patients With Moderate to Severe Psoriasis

September 28th 2023

Compared with other biologics frequently used in China for moderate-to-severe psoriasis, secukinumab is the most cost-effective treatment option.

brain colorful | Image credit: vegefox - stock.adobe.com
EC Approves First MS Biosimilar; Coherus Receives CRL for Neulasta Onpro Competitor

September 27th 2023

Japan flag in Tokyo | Image credit: Savvapanf Photo © - stock.adobe.com
Alvotech’s Stelara Biosimilar Approved in Japan

September 25th 2023

Doctor with human Eye anatomy model | Image Credit: ©  Jo Panuwat D- stock.adobe.com
Higher-Cost Therapies for ARMD Could Contribute to Heightened Medicare Costs; Biosimilars Could Help

September 24th 2023

old woman eye | Image credit: Syda Productions - stock.adobe.com
European Commission Approves First Aflibercept Biosimilar

September 21st 2023

Video Interviews
Podcasts
CfB podcast banner
CFB podcast banner
CfB podcast banner
cfb podcast banner
CfB podcast banner
cfb podcast banner
image of adalimumab biosmilar eveloped by alvotech prefilled syring
CfB podcast banner
CfB podcast banner
CfB podcast banner

More News

© 2023 MJH Life Sciences

All rights reserved.